(Q40557870)

21 September 2017

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors (English)

1 reference

21 September 2017

Peter M Smith-Jones

1

1 reference

21 September 2017

David B Solit

2

1 reference

21 September 2017

Timothy Akhurst

3

1 reference

21 September 2017

Farzana Afroze

4

1 reference

21 September 2017

Neal Rosen

5

1 reference

21 September 2017

Steven M Larson

6

1 reference

21 September 2017

language of work or name

1 reference

9 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

22

1 reference

21 September 2017

701-706

1 reference

21 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt968

21 September 2017

0 references

cites work

Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy

1 reference

Advances in targeted therapy for chronic myeloid leukemia.

21 January 2018

1 reference

Current issues in the management of acute promyelocytic leukemia

21 January 2018

1 reference

Is there a cloud in the silver lining for imatinib?

21 January 2018

1 reference

Advances in the understanding and management of acute promyelocytic leukemia

21 January 2018

1 reference

The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors

21 January 2018

1 reference

HER-targeted tyrosine-kinase inhibitors

21 January 2018

1 reference

Growth factor receptors in breast cancer: potential for therapeutic intervention.

21 January 2018

1 reference

Perspectives on anti-HER monoclonal antibodies

21 January 2018

1 reference

Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer

21 January 2018

1 reference

Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer

21 January 2018

1 reference

ZD1839 (Iressa) in non-small cell lung cancer

21 January 2018

1 reference

Hsp90 inhibitors as novel cancer chemotherapeutic agents

21 January 2018

1 reference

Clinical Experience with Trastuzumab (Herceptin)

21 January 2018

1 reference

Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma

21 January 2018

1 reference

Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells.

21 January 2018

1 reference

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NBT968

1 reference

21 September 2017

1 reference